{"transactions":[{"id":827901,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2026-03-26T20:52:09.000Z","date":"2026-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":126028,"price":0.694,"value":87463.432,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 24, 2026."}],"balance_after":2485606,"source":{"system":"sec-edgar","filing":"0001437749-26-009967","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926009967/rdgdoc.xml","form_type":"4"}},{"id":833010,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2026-03-20T19:15:14.000Z","date":"2026-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":22425,"price":0.6346,"value":14230.905,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2026."}],"balance_after":2611634,"source":{"system":"sec-edgar","filing":"0001437749-26-009206","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926009206/rdgdoc.xml","form_type":"4"}},{"id":836284,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-19T01:44:44.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":1543000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 16, 2027, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 16, 2030."}],"balance_after":1543000,"derivative":{"exercise_price":0.6795,"expiration_date":"2036-03-16","underlying":"Common Stock","underlying_shares":1543000},"source":{"system":"sec-edgar","filing":"0001437749-26-008925","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926008925/rdgdoc.xml","form_type":"4"}},{"id":836283,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2026-03-19T01:44:44.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":846500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 16, 2026, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":2634059,"source":{"system":"sec-edgar","filing":"0001437749-26-008925","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926008925/rdgdoc.xml","form_type":"4"}},{"id":978472,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2025-12-09T02:43:35.000Z","date":"2025-12-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":54153,"price":0.37,"value":20036.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 4, 2025."}],"balance_after":1787559,"source":{"system":"sec-edgar","filing":"0001437749-25-037206","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925037206/rdgdoc.xml","form_type":"4"}},{"id":978471,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2025-12-09T02:43:35.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":151351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units, which fully vested on December 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 57,723 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan."}],"balance_after":1841712,"source":{"system":"sec-edgar","filing":"0001437749-25-037206","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925037206/rdgdoc.xml","form_type":"4"}},{"id":1144455,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2025-05-19T22:49:39.000Z","date":"2025-05-19","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.49,"value":49000.0,"ownership":{"direct":false,"nature":"By The Lo Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents 100,000 shares held by The Lo Family Trust, of which Mr. Lo is a trustee and a beneficiary."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001437749-25-017678","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925017678/rdgdoc.xml","form_type":"4"}},{"id":1191798,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-27T01:54:36.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":2108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029."}],"balance_after":2108000,"derivative":{"exercise_price":0.5126,"expiration_date":"2035-03-24","underlying":"Common Stock","underlying_shares":2108000},"source":{"system":"sec-edgar","filing":"0001437749-25-009452","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925009452/rdgdoc.xml","form_type":"4"}},{"id":1191797,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2025-03-27T01:54:36.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":1405000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":1632638,"source":{"system":"sec-edgar","filing":"0001437749-25-009452","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925009452/rdgdoc.xml","form_type":"4"}},{"id":1196497,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:28:43.000Z","date":"2025-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":22362,"price":0.5702,"value":12750.8124,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025."}],"balance_after":227638,"source":{"system":"sec-edgar","filing":"0001437749-25-008651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925008651/rdgdoc.xml","form_type":"4"}},{"id":1566701,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-21T00:03:48.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028."}],"balance_after":1000000,"derivative":{"exercise_price":1.16,"expiration_date":"2034-03-17","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001437749-24-008748","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008748/rdgdoc.xml","form_type":"4"}},{"id":1566700,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"President, Chief Exec Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:03:48.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001437749-24-008748","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008748/rdgdoc.xml","form_type":"4"}},{"id":2239966,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-07T23:37:48.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":442,"price":0.71,"value":313.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022."}],"balance_after":13163,"source":{"system":"sec-edgar","filing":"0000899243-22-021396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000089924322021396/doc4.xml","form_type":"4"}},{"id":2310835,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-02T01:07:19.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":23633,"price":0.2101,"value":4965.2933,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer."}],"balance_after":460709,"source":{"system":"sec-edgar","filing":"0001567619-22-007909","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761922007909/doc1.xml","form_type":"4"}},{"id":2538889,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-20T01:34:22.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":237500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule."}],"balance_after":237500,"derivative":{"exercise_price":0.6342,"expiration_date":"2031-10-14","underlying":"Common Stock","underlying_shares":237500},"source":{"system":"sec-edgar","filing":"0001567619-21-018472","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921018472/doc1.xml","form_type":"4"}},{"id":2538888,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-20T01:34:22.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":118750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 118,750 RSUs which are subject to performance vesting."}],"balance_after":484342,"source":{"system":"sec-edgar","filing":"0001567619-21-018472","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921018472/doc1.xml","form_type":"4"}},{"id":2678865,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-07T22:44:07.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":13158,"price":0.805,"value":10592.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units of the Issuer."}],"balance_after":365592,"source":{"system":"sec-edgar","filing":"0001567619-21-011790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921011790/doc1.xml","form_type":"4"}},{"id":2763455,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T01:33:55.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":465000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on  March 30, 2021, so that all shares shall have vested on March 30, 2025."}],"balance_after":465000,"derivative":{"exercise_price":1.2,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":465000},"source":{"system":"sec-edgar","filing":"0001567619-21-007415","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921007415/doc1.xml","form_type":"4"}},{"id":2763454,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-02T01:33:55.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":232500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in substantially equal annual installments on each of the first four anniversaries of  March 30, 2021, subject to the Reporting Person's continued service to the Issuer on each applicable vesting date."}],"balance_after":378750,"source":{"system":"sec-edgar","filing":"0001567619-21-007415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921007415/doc1.xml","form_type":"4"}},{"id":2777303,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-19T22:13:08.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The?shares?underlying?the?option?vest?in 30 equal installments on each monthly anniversary?of?the?date?of?grant."}],"balance_after":450000,"derivative":{"exercise_price":1.37,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001567619-21-006704","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761921006704/doc1.xml","form_type":"4"}},{"id":3097396,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-30T01:55:42.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":146250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in substantially equal annual installments on each of the first four anniversaries of June 3, 2020, subject to the Reporting Person's continued service to the Issuer on each applicable vesting date."}],"balance_after":146250,"source":{"system":"sec-edgar","filing":"0001140361-20-015097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000114036120015097/form4.xml","form_type":"4"}},{"id":3119932,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T21:11:16.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":292500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on June 3, 2020, so that all shares shall have vested on June 3, 2024."}],"balance_after":292500,"derivative":{"exercise_price":1.01,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":292500},"source":{"system":"sec-edgar","filing":"0001567619-20-011814","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761920011814/doc1.xml","form_type":"4"}},{"id":3389091,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-23T20:28:12.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares underlying the stock option vest on October 21, 2020, and the remaining underlying shares vest in equal monthly installments over the following three-year period."}],"balance_after":450000,"derivative":{"exercise_price":1.94,"expiration_date":"2029-10-20","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001567619-19-019924","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501959/000156761919019924/doc1.xml","form_type":"4"}},{"id":3456670,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2019-07-24T20:38:22.000Z","date":"2019-07-22","kind":"sale","acquired":false,"shares":1852,"price":10.043,"value":18599.636,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.04 to $10.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":19557,"source":{"system":"sec-edgar","filing":"0001209191-19-043050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119043050/doc4.xml","form_type":"4"}},{"id":3667925,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2019-02-08T22:39:36.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Option Vesting Commencement Date\") of the option is January 1, 2019. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Option Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Option Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":36300,"derivative":{"exercise_price":27.76,"expiration_date":"2029-02-05","underlying":"COMMON STOCK","underlying_shares":36300},"source":{"system":"sec-edgar","filing":"0001209191-19-008693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119008693/doc4.xml","form_type":"4"}},{"id":3687970,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2019-01-24T21:54:16.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":2114,"price":24.9118,"value":52663.5452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.91 to $24.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":21409,"source":{"system":"sec-edgar","filing":"0001209191-19-005188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119005188/doc4.xml","form_type":"4"}},{"id":3862165,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2018-07-24T21:10:20.000Z","date":"2018-07-20","kind":"sale","acquired":false,"shares":1839,"price":51.8543,"value":95360.0577,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.525, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":23523,"source":{"system":"sec-edgar","filing":"0001209191-18-043775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118043775/doc4.xml","form_type":"4"}},{"id":4062600,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2018-02-13T23:02:38.000Z","date":"2018-02-11","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is January 1, 2018. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":33000,"derivative":{"exercise_price":60.85,"expiration_date":"2028-02-10","underlying":"COMMON STOCK","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-18-009711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118009711/doc4.xml","form_type":"4"}},{"id":4090989,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2018-01-24T21:38:39.000Z","date":"2018-01-22","kind":"sale","acquired":false,"shares":1858,"price":92.85,"value":172515.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":25362,"source":{"system":"sec-edgar","filing":"0001209191-18-005139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118005139/doc4.xml","form_type":"4"}},{"id":4252580,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2017-07-24T21:16:30.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":1990,"price":94.901,"value":188852.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":27220,"source":{"system":"sec-edgar","filing":"0001209191-17-046092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117046092/doc4.xml","form_type":"4"}},{"id":4435875,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-02-21T21:43:28.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is February 16, 2017. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer; provided, however, that if the Reporting Person experiences a Qualifying Termination (as defined in the letter agreement between the Issuer and the Reporting Person) on or within eighteen (18) months following a Change in Control (as defined in the Issuer's 2011 Incentive Award Plan), then the option shall vest and become exercisable upon the effectiveness of the Release (as defined in the letter agreement)."}],"balance_after":31500,"derivative":{"exercise_price":37.35,"expiration_date":"2027-02-15","underlying":"COMMON STOCK","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-17-012746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117012746/doc4.xml","form_type":"4"}},{"id":4482918,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2017-01-24T22:56:10.000Z","date":"2017-01-20","kind":"sale","acquired":false,"shares":2290,"price":33.2351,"value":76108.379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":29210,"source":{"system":"sec-edgar","filing":"0001209191-17-005354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117005354/doc4.xml","form_type":"4"}},{"id":4579578,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":55946,"kind":"person","name":"Lo Steven","position":1,"cik":"0001501959","reported_name":"Lo Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"COMMON STOCK","published_at":"2016-10-15T01:19:33.000Z","date":"2016-10-14","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in six substantially equal installments on each six-month anniversary of the Vesting Commencement Date of July 19, 2016, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":31500,"source":{"system":"sec-edgar","filing":"0001209191-16-145981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919116145981/doc4.xml","form_type":"4"}}]}